97 related articles for article (PubMed ID: 12934314)
41. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
42. Alleviation of the climacteric symptoms with oral sequential hormone replacement therapy.
Chittacharoen A; Domhardt R; Manonai J; Theppisai U; Golbs S
J Med Assoc Thai; 2004 Jan; 87(1):1-7. PubMed ID: 14971528
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of drug therapy and risk factors in diabetic hypertensives: a study of the quality of care provided in diabetic clinics in Bahrain.
Al Khaja KA; P Sequeira R; Damanhori AH
J Eval Clin Pract; 2005 Apr; 11(2):121-31. PubMed ID: 15813710
[TBL] [Abstract][Full Text] [Related]
44. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
45. Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
Al-Farra HM; Al-Fahoum SK; Tabbaa MA
Saudi Med J; 2005 Dec; 26(12):1930-5. PubMed ID: 16380775
[TBL] [Abstract][Full Text] [Related]
46. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Demir B; Ozturkoglu E; Solaroglu A; Baskan B; Kandemir O; Karabulut E; Haberal A
Gynecol Endocrinol; 2008 Jun; 24(6):347-53. PubMed ID: 18584415
[TBL] [Abstract][Full Text] [Related]
47. Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.
Preston RA; White WB; Pitt B; Bakris G; Norris PM; Hanes V
Am J Hypertens; 2005 Jun; 18(6):797-804. PubMed ID: 15925739
[TBL] [Abstract][Full Text] [Related]
48. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
49. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlöf B; Velazquez EJ; Gupte J; Staikos L; Hua TA; Shi V; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M;
Blood Press; 2008; 17(1):7-17. PubMed ID: 18568687
[TBL] [Abstract][Full Text] [Related]
50. [Characteristics of hypotensive effect in patients with arterial hypertension and desaturation signs of obstructive sleep apnea syndrome during sleep].
Zelveian PA; Oshchepkova EV; Buniatian MS; Rogoza AN
Ter Arkh; 2004; 76(6):81-4. PubMed ID: 15332583
[TBL] [Abstract][Full Text] [Related]
51. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women.
Kwok S; Charlton-Menys V; Pemberton P; McElduff P; Durrington PN
Maturitas; 2006 Mar; 53(4):439-46. PubMed ID: 16139447
[TBL] [Abstract][Full Text] [Related]
52. Two routes of hormonal replacement therapy in symptomatic menopausal women after kidney transplantation.
Pietrzak B; Wielgos M; Kaminski P; Bobrowska K
Neuro Endocrinol Lett; 2006 Jun; 27(3):387-91. PubMed ID: 16816826
[TBL] [Abstract][Full Text] [Related]
53. [Combined treatment of arterial hypertension (results of the international program CLIP-ACCORD)].
Chazova IE; Ratova LG
Ter Arkh; 2009; 81(5):60-4. PubMed ID: 19537589
[TBL] [Abstract][Full Text] [Related]
54. Pulse pressure monitoring of open antihypertensive therapy.
Safar ME; Vaisse B; Blacher J; Rudnichi A; Mourad JJ
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1088-94. PubMed ID: 15607613
[TBL] [Abstract][Full Text] [Related]
55. Added benefits of drospirenone for compliance.
Foidart JM
Climacteric; 2005 Oct; 8 Suppl 3():28-34. PubMed ID: 16203653
[TBL] [Abstract][Full Text] [Related]
56. The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva.
Yalçin F; Gurgan S; Gurgan T
J Contemp Dent Pract; 2005 May; 6(2):10-7. PubMed ID: 15915200
[TBL] [Abstract][Full Text] [Related]
57. Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women.
Graff-Iversen S; Hammar N; Thelle DS; Tonstad S
J Intern Med; 2004 Nov; 256(5):437-45. PubMed ID: 15485480
[TBL] [Abstract][Full Text] [Related]
58. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
59. [The menopause. Therapeutic regimens].
Derrien J
Rev Fr Gynecol Obstet; 1985 Mar; 80(4):223-5. PubMed ID: 3992124
[TBL] [Abstract][Full Text] [Related]
60. [The menopause. Therapeutic measures].
Rozenbaum H
Rev Fr Gynecol Obstet; 1985 Mar; 80(4):227-9. PubMed ID: 3992125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
